Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Julphar
Citi
Moodys
Accenture
QuintilesIMS
Merck
Daiichi Sankyo
Farmers Insurance
Federal Trade Commission

Generated: February 25, 2018

DrugPatentWatch Database Preview

SODIUM IODIDE I 131 Drug Profile

« Back to Dashboard

When do Sodium Iodide I 131 patents expire, and when can generic versions of Sodium Iodide I 131 launch?

Sodium Iodide I 131 is a drug marketed by CIS, Jubilant Draximage, and Mallinkrodt Nuclear. and is included in five NDAs.

The generic ingredient in SODIUM IODIDE I 131 is sodium iodide i-131. There are one thousand four hundred and fifteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the sodium iodide i-131 profile page.
Drug patent expirations by year for SODIUM IODIDE I 131
Pharmacology for SODIUM IODIDE I 131

US Patents and Regulatory Information for SODIUM IODIDE I 131

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cis SODIUM IODIDE I 131 sodium iodide i-131 CAPSULE;ORAL 017316-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mallinkrodt Nuclear SODIUM IODIDE I 131 sodium iodide i-131 CAPSULE;ORAL 016517-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Jubilant Draximage SODIUM IODIDE I 131 sodium iodide i-131 CAPSULE;ORAL 021305-004 Nov 18, 2004 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Cis SODIUM IODIDE I 131 sodium iodide i-131 SOLUTION;ORAL 017315-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Cis SODIUM IODIDE I 131 sodium iodide i-131 CAPSULE;ORAL 017316-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Jubilant Draximage SODIUM IODIDE I 131 sodium iodide i-131 CAPSULE;ORAL 021305-006 May 19, 2005 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mallinkrodt Nuclear SODIUM IODIDE I 131 sodium iodide i-131 CAPSULE;ORAL 016517-001 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mallinkrodt Nuclear SODIUM IODIDE I 131 sodium iodide i-131 CAPSULE;ORAL 016515-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mallinkrodt Nuclear SODIUM IODIDE I 131 sodium iodide i-131 SOLUTION;ORAL 016515-001 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Dow
Julphar
US Army
Cerilliant
Argus Health
Express Scripts
Chinese Patent Office
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot